Thus, in this study, the modulation of the activity of LKB1/AMPK and PI3K/Akt pathways by SAMC administration may partly be involved in its antiapoptotic effect during NAFLD development. This evidence concerns the gene AKT1 and metabolic dysfunction-associated steatotic liver disease.